Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
Atherosclerosis
|
July 20, 2015
Effect of Lactobacillus casei Shirota supplementation on trimethylamine-N-oxide levels in patients with metabolic syndrome: An open-label, randomized study
Norbert J Tripolt, Bettina Leber, Alexander Triebl, et al.
Scientific Reports
|
December 22, 2025
Carbohydrate antigen 125 (CA125) following acute myocardial infarction: effects of empagliflozin and association with heart failure readouts in the EMMY trial
Ahmed M Hassan, Faisal Aziz, Norbert J Tripolt, et al.
Cardiovascular Diabetology
|
June 3, 2014
Multiple risk factor intervention reduces carotid atherosclerosis in patients with type 2 diabetes
Norbert J Tripolt, Sophie H Narath, Michaela Eder, et al.
Cardiovascular Diabetology
|
September 12, 2024
Effects of dietary interventions and intermittent fasting on HDL function in obese individuals with T2DM: a randomized controlled trial
Anja Pammer, Anna Obermayer, Julia T Stadler, et al.
Cardiovascular Diabetology
|
July 20, 2023
Alterations in trimethylamine-N-oxide in response to Empagliflozin therapy: a secondary analysis of the EMMY trial
Faisal Aziz, Norbert J Tripolt, Peter N Pferschy, et al.
Cardiovascular Diabetology
|
April 27, 2024
Ketone body levels and its associations with cardiac markers following an acute myocardial infarction: a post hoc analysis of the EMMY trial
Faisal Aziz, Norbert J Tripolt, Peter N Pferschy, et al.
Canadian Journal of Diabetes
|
June 23, 2020
Efficacy of Carbohydrate Supplementation Compared With Bolus Insulin Dose Reduction Around Exercise in Adults With Type 1 Diabetes: A Retrospective, Controlled Analysis
Max L Eckstein, Olivia McCarthy, Norbert J Tripolt, et al.
Diabetes, Obesity & Metabolism
|
December 7, 2020
Rapid glucose rise reduces heart rate variability in adults with type 1 diabetes: A prospective secondary outcome analysis
Max L Eckstein, Othmar Moser, Norbert J Tripolt, et al.
Trials
|
October 14, 2016
The effects of linagliptin on endothelial function and global arginine bioavailability ratio in coronary artery disease patients with early diabetes: study protocol for a randomized controlled trial
Norbert J Tripolt, Felix Aberer, Regina Riedl, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
April 16, 2026
Safety and efficacy of intermittent fasting with or without exercise in people living with overweight or obesity and type 2 diabetes-The INTERFAST-3 study design
Caren Sourij, Alexander Müller, Abdullah Al-Baghdadi, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
Atherosclerosis
|
July 20, 2015
Effect of Lactobacillus casei Shirota supplementation on trimethylamine-N-oxide levels in patients with metabolic syndrome: An open-label, randomized study
Norbert J Tripolt, Bettina Leber, Alexander Triebl, et al.
Scientific Reports
|
December 22, 2025
Carbohydrate antigen 125 (CA125) following acute myocardial infarction: effects of empagliflozin and association with heart failure readouts in the EMMY trial
Ahmed M Hassan, Faisal Aziz, Norbert J Tripolt, et al.
Cardiovascular Diabetology
|
June 3, 2014
Multiple risk factor intervention reduces carotid atherosclerosis in patients with type 2 diabetes
Norbert J Tripolt, Sophie H Narath, Michaela Eder, et al.
Cardiovascular Diabetology
|
September 12, 2024
Effects of dietary interventions and intermittent fasting on HDL function in obese individuals with T2DM: a randomized controlled trial
Anja Pammer, Anna Obermayer, Julia T Stadler, et al.
Cardiovascular Diabetology
|
July 20, 2023
Alterations in trimethylamine-N-oxide in response to Empagliflozin therapy: a secondary analysis of the EMMY trial
Faisal Aziz, Norbert J Tripolt, Peter N Pferschy, et al.
Cardiovascular Diabetology
|
April 27, 2024
Ketone body levels and its associations with cardiac markers following an acute myocardial infarction: a post hoc analysis of the EMMY trial
Faisal Aziz, Norbert J Tripolt, Peter N Pferschy, et al.
Canadian Journal of Diabetes
|
June 23, 2020
Efficacy of Carbohydrate Supplementation Compared With Bolus Insulin Dose Reduction Around Exercise in Adults With Type 1 Diabetes: A Retrospective, Controlled Analysis
Max L Eckstein, Olivia McCarthy, Norbert J Tripolt, et al.
Diabetes, Obesity & Metabolism
|
December 7, 2020
Rapid glucose rise reduces heart rate variability in adults with type 1 diabetes: A prospective secondary outcome analysis
Max L Eckstein, Othmar Moser, Norbert J Tripolt, et al.
Trials
|
October 14, 2016
The effects of linagliptin on endothelial function and global arginine bioavailability ratio in coronary artery disease patients with early diabetes: study protocol for a randomized controlled trial
Norbert J Tripolt, Felix Aberer, Regina Riedl, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
April 16, 2026
Safety and efficacy of intermittent fasting with or without exercise in people living with overweight or obesity and type 2 diabetes-The INTERFAST-3 study design
Caren Sourij, Alexander Müller, Abdullah Al-Baghdadi, et al.
Page
of 4